The rising global prevalence of malignancies and anemia is propelling the global bone marrow transplant market forward. Furthermore, technological advancements, improved healthcare infrastructure, new indications for bone marrow transplantation for heart and neuronal disorders, growing investment in logistic services, and rising per capita healthcare expenditure are all expected to boost the global bone marrow transplantation market.
Because of the low treatment cost and high success rate, the autologous bone marrow transplant segment of the transplant type is predicted to dominate the worldwide bone marrow transplant market. Because leukemia is the most likely condition to benefit from a bone marrow transplant, it is expected to account for the largest share of the worldwide bone marrow transplant market.
Read more @
https://creativeedge16.blogspot.com/2022/01/global-bone-marrow-transplant-market-is.html
